Aktienanalyse zu DLH Holdings Corp (DLHC)DLHCDLH Holdings Corp

DLH Holdings Corp. is a provider of science research and development, systems engineering and integration, and digital transformation and cyber security solutions to federal agencies. The Company is focused on improved deployment of health and defense initiatives for multiple agencies within the federal government, including the Department of Health and Human Services and Department of Defense. Its digital transformation and cyber security solutions include tools, such as artificial intelligence and machine learning, cloud enablement, cybersecurity ecosystem, big data analytics, and modeling and simulation. The Company's science research and development solutions include data analytics, testing and evaluation, clinical trials research services, and epidemiology studies. Its systems engineering and integration solutions include system modernization, modeling, simulation & training, technology-enabled health solutions, software development, and robotics and unmanned systems. It operates in the Technology sector (SERVICES-HELP SUPPLY SERVICES industry).

DLH Holdings Corp is not a strong buy right now due to significant financial losses and declining revenue, with a current price of $4.4 and a forward P/E of 17.45, suggesting that while the stock is undervalued, the risks are substantial. The company reported a net income loss of $16.79 million in Q3 2026, which raises concerns about its financial health.

2 analysts cover DLHC: 2 rate it Buy, 0 Hold and 0 Sell. The average price target is 10.00.